0001567619-22-002014.txt : 20220128 0001567619-22-002014.hdr.sgml : 20220128 20220128210255 ACCESSION NUMBER: 0001567619-22-002014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Quirk Erin CENTRAL INDEX KEY: 0001843038 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39926 FILM NUMBER: 22570966 MAIL ADDRESS: STREET 1: C/O TERNS PHARMACEUTICALS, INC. STREET 2: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Terns Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001831363 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-525-5535 EXT.101 MAIL ADDRESS: STREET 1: 1065 EAST HILLSDALE BLVD., SUITE 100 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc1.xml FORM 4 X0306 4 2022-01-26 0 0001831363 Terns Pharmaceuticals, Inc. TERN 0001843038 Quirk Erin C/O TERNS PHARMACEUTICALS, INC. 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 0 1 0 0 President, CMO and Head of R&D Stock Option (Right to Buy) 5.36 2022-01-26 4 A 0 92500 0.00 A 2032-01-26 Common Stock 92500 92500 D 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date. /s/ Bryan Yoon, as Attorney-in-Fact for Erin Quirk 2022-01-28